Global Actinic Keratosis Treatment Market is Expected to grow at a CAGR of 4.7% During Forecast 2020-2026
The global actinic keratosis treatment market is anticipated to exhibit a CAGR of 4.7% during the forecast period (2020-2026). The rising advancement in actinic keratosis treatment options is anticipated to drive the growth of the global market. Cumulative sun exposure is the single most important cause of actinic keratosis. Lesion-specific therapy, field therapy, and PDT are the major therapies that are being used in the treatment of actinic keratosis. Cryotherapy using liquid nitrogen is a commonly used therapy for actinic keratosis treatment. This method destroys the keratinocytes through freezing, while mostly preserving important dermal structures such as blood vessels, nerves, and collagen due to their higher resistance to cold.
To Request a Sample of our Report on Global Actinic
Keratosis Treatment Market: https://www.omrglobal.com/request-sample/actinic-keratosis-treatment-market
Field therapy involves the treatment of an entire
face (field) that is marked by the presence of visible actinic keratosis. It is
increasingly accepted as another modality of treatment as it treats visible
actinic keratosis and expanded clones of dysplastic cells at the subclinical
and cellular level in that region of UV damaged skin as well. Good tolerability
and efficacy, and the excellent cosmetic outcome are the major benefits of
field therapy. PDT therapy involves the application of a pre-photosensitizer to
the area of the skin being treated. The phototoxic reactions can cause adverse
events such as erythema, stinging, itching, oedema, and exudation. This factor
may restrain the adoption of this therapy for the treatment of actinic
keratosis across the globe.
Market Coverage
·
The market number available for – 2019-2026-
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Treatment Type, End-User
·
Regions Covered- North America, Europe, Asia-Pacific,
Rest of the World
·
Competitive Landscape- Bausch Health Companies, Inc.,
Biofrontera AG, BioLineRx, Ltd., Cipher Pharmaceuticals, Inc., Galderma S.A.,
Hill Dermaceuticals, Inc., LEO Pharma A/S, Valeant Pharmaceuticals Inc., and so
on
A
full Report of Global Actinic Keratosis Treatment Market is Available
at: https://www.omrglobal.com/industry-reports/actinic-keratosis-treatment-market
Global Actinic Keratosis Treatment Market Report Segment
By Type
·
Medication
·
Therapy
·
Other
By End-User
·
Hospitals & Oncology Centers
·
Dermatology Clinics
Global Actinic Keratosis Treatment Market Report Segment
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
3M Co.
·
Alma Lasers, Inc.
·
Almirall, S.A.
·
Bausch Health Companies Inc.
·
Biofrontera AG
·
BioLineRx, Ltd.
·
Cipher Pharmaceuticals, Inc.
·
Galderma S.A.
·
Hill Dermaceuticals, Inc.
·
LEO Pharma A/S
·
Mylan N.V.
·
Stanford Chemicals Company
·
Sun Pharmaceutical Industries, Ltd.
·
Teva Pharmaceutical Industries, Ltd.
·
Valeant Pharmaceuticals, Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment